← All Sponsors
SPONSOR

Maastricht Radiation Oncology

Total Trials
2
Recruiting
2
Phases
N/A

Maastricht Radiation Oncology is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Low-grade Glioma, High Grade Glioma, Prostate Cancer, Prostate Cancer Metastatic Disease.

Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Maastricht Radiation Oncology

How many clinical trials has Maastricht Radiation Oncology sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Maastricht Radiation Oncology, of which 2 are actively recruiting participants. These trials cover conditions including Low-grade Glioma, High Grade Glioma, Prostate Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Maastricht Radiation Oncology research focus on?
Maastricht Radiation Oncology clinical trials span Low-grade Glioma, High Grade Glioma, Prostate Cancer, Prostate Cancer Metastatic Disease, Prostate Cancer Recurrent, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Maastricht Radiation Oncology clinical trial?
To participate in a Maastricht Radiation Oncology trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Maastricht Radiation Oncology trials with current recruitment status updated daily.

Clinical Trials by Maastricht Radiation Oncology

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology